|
WO2014117121A1
(en)
|
2013-01-28 |
2014-07-31 |
St. Jude Children's Research Hospital, Inc. |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
SG11201507688VA
(en)
*
|
2013-03-15 |
2015-10-29 |
Sloan Kettering Inst Cancer |
Compositions and methods for immunotherapy
|
|
EP3789487A1
(en)
*
|
2013-04-03 |
2021-03-10 |
Memorial Sloan Kettering Cancer Center |
Effective generation of tumor-targeted t-cells derived from pluripotent stem cells
|
|
SG11201603484PA
(en)
|
2013-11-21 |
2016-05-30 |
Ucl Business Plc |
Cell
|
|
KR20210014210A
(ko)
|
2014-05-15 |
2021-02-08 |
내셔널 유니버시티 오브 싱가포르 |
변형된 천연 살해 세포 및 그의 용도
|
|
AU2015344769B2
(en)
*
|
2014-11-12 |
2020-07-09 |
Allogene Therapeutics, Inc. |
Inhibitory chimeric antigen receptors
|
|
EP3227323B1
(en)
|
2014-12-03 |
2020-08-05 |
Juno Therapeutics, Inc. |
Methods and compositions for adoptive cell therapy
|
|
PT3560953T
(pt)
|
2014-12-24 |
2024-03-26 |
Autolus Ltd |
Célula
|
|
EP3250680A4
(en)
|
2015-01-26 |
2018-12-05 |
Fate Therapeutics, Inc. |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
KR102632082B1
(ko)
*
|
2015-02-27 |
2024-02-02 |
아이셀 진 테라퓨틱스 엘엘씨 |
혈액 악성종양을 표적으로 하는 키메라 항원 수용체(car), 조성물 및 이의 용도
|
|
WO2016179319A1
(en)
*
|
2015-05-04 |
2016-11-10 |
Cellerant Therapeutics, Inc. |
Chimeric antigen receptors with ctla4 signal transduction domains
|
|
MX2017014822A
(es)
|
2015-05-18 |
2018-04-30 |
Tcr2 Therapeutics Inc |
Composiciones y métodos para la reprogramación del tcr con proteínas de fusión.
|
|
GB201509413D0
(en)
*
|
2015-06-01 |
2015-07-15 |
Ucl Business Plc |
Fusion protein
|
|
CA2997551A1
(en)
|
2015-09-04 |
2017-03-09 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
|
US20180291080A1
(en)
*
|
2015-09-28 |
2018-10-11 |
Trustees Of Dartmouth College |
Chimeric antigen receptor, regulatory cells and methods of use
|
|
SG11201803145RA
(en)
|
2015-11-04 |
2018-05-30 |
Fate Therapeutics Inc |
Methods and compositions for inducing hematopoietic cell differentiation
|
|
AU2016349504B2
(en)
|
2015-11-04 |
2023-02-09 |
Fate Therapeutics, Inc. |
Genomic engineering of pluripotent cells
|
|
US20210206826A1
(en)
*
|
2015-11-19 |
2021-07-08 |
The Regents Of The University Of California |
Conditionally repressible immune cell receptors and methods of use thereof
|
|
JP7123794B2
(ja)
|
2015-12-09 |
2022-08-23 |
メモリアル スローン ケタリング キャンサー センター |
免疫細胞組成物及びそれを使用する方法
|
|
EP3408671B1
(en)
|
2016-01-25 |
2023-11-01 |
F. Hoffmann-La Roche AG |
Methods for assaying t-cell dependent bispecific antibodies
|
|
CN105567640A
(zh)
*
|
2016-01-27 |
2016-05-11 |
苏州佰通生物科技有限公司 |
一种嵌合抗原受体脂肪干细胞及其制备方法
|
|
CA3018253A1
(en)
*
|
2016-03-31 |
2017-10-05 |
University Of Southern California |
A highly sensitive and specific luciferase based reporter assay for antigen detection
|
|
ES2937699T3
(es)
*
|
2016-04-22 |
2023-03-30 |
Crage Medical Co Ltd |
Composiciones y métodos de inmunoterapia celular
|
|
CN109477830A
(zh)
*
|
2016-05-25 |
2019-03-15 |
昆士兰医学研究所理事会 |
免疫疗法的方法
|
|
CN105950561A
(zh)
*
|
2016-05-26 |
2016-09-21 |
江苏杰晟生物科技有限公司 |
一种靶向乳腺癌干细胞的双特异性嵌合抗原受体基因修饰的t淋巴细胞的制备方法及其产品
|
|
CN109562127A
(zh)
*
|
2016-06-03 |
2019-04-02 |
纪念斯隆-凯特琳癌症中心 |
作为早期治疗选择的过继细胞疗法
|
|
CA3032498A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
GB201614162D0
(en)
*
|
2016-08-18 |
2016-10-05 |
Polytherics Ltd |
Antibodies, uses thereof and conjugates thereof
|
|
CA3034691A1
(en)
|
2016-08-30 |
2018-03-08 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use for treating viral and other infections
|
|
JP2019530456A
(ja)
|
2016-09-28 |
2019-10-24 |
ガビッシュ−ガリラヤ バイオ アプリケーションズ リミテッド |
癌の新規抗原性シグネチャーを標的としたｃａｒ療法のためのユニバーサルプラットフォーム
|
|
MX2019003899A
(es)
|
2016-10-07 |
2019-08-14 |
Tcr2 Therapeutics Inc |
Composiciones y metodos para reprogramacion de receptores de linfocitos t mediante el uso de proteinas de fusion.
|
|
CN107988164B
(zh)
|
2016-10-26 |
2020-07-07 |
阿思科力(苏州)生物科技有限公司 |
一种pd-1 car nk-92细胞及其制备方法与应用
|
|
EP3315511A1
(en)
*
|
2016-10-29 |
2018-05-02 |
Miltenyi Biotec GmbH |
Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens
|
|
EP3544996A2
(en)
|
2016-11-22 |
2019-10-02 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
CN108204958A
(zh)
*
|
2016-12-19 |
2018-06-26 |
伊缪泰普有限公司 |
结合测定
|
|
EP3558346A1
(en)
*
|
2016-12-21 |
2019-10-30 |
Danmarks Tekniske Universitet |
Antigen presenting scaffolds for immune-cell manipulation
|
|
CN110121505B
(zh)
*
|
2016-12-28 |
2023-08-01 |
株式会社绿十字细胞治疗 |
嵌合抗原受体和表达其的自然杀伤细胞
|
|
AU2018231190B2
(en)
*
|
2017-03-08 |
2023-05-25 |
Memorial Sloan Kettering Cancer Center |
Immune cell compositions and methods of use
|
|
CA3056439A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Truncated nkg2d chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
AU2018245749A1
(en)
|
2017-03-27 |
2019-10-03 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
CN109097401B
(zh)
*
|
2017-03-31 |
2021-09-07 |
国健呈诺生物科技(北京)有限公司 |
一种重组载体CAR-CD244-antiPSMA的制备方法
|
|
JP2020517259A
(ja)
*
|
2017-04-19 |
2020-06-18 |
ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム |
操作された抗原受容体を発現する免疫細胞
|
|
GB201707779D0
(en)
*
|
2017-05-15 |
2017-06-28 |
Autolus Ltd |
Cell
|
|
CN111201438A
(zh)
*
|
2017-06-02 |
2020-05-26 |
朱诺治疗学股份有限公司 |
与和细胞疗法相关的毒性有关的制品和方法
|
|
HUE061502T2
(hu)
*
|
2017-09-28 |
2023-07-28 |
Immpact Bio Ltd |
Univerzális platform gátló kiméra antigén receptor (ICAR) elõállítására
|
|
CN109593721B
(zh)
*
|
2017-09-30 |
2022-11-01 |
亘喜生物科技（上海）有限公司 |
具有自杀基因开关的靶向人间皮素的工程化免疫细胞
|
|
GB201717524D0
(en)
|
2017-10-25 |
2017-12-06 |
Autolus Ltd |
Vectors
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
AU2018370195B2
(en)
|
2017-11-14 |
2022-01-13 |
Green Cross Lab Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
EP3720882A4
(en)
|
2017-12-05 |
2021-10-27 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
T-CELLS WITH TWO DIFFERENT CHIMERIC ANTIGEN RECEPTORS AND THEIR USE
|
|
IL316570A
(en)
|
2017-12-05 |
2024-12-01 |
Medical Res Infrastructure & Health Services Fund Tel Aviv Medical Ct |
T cells containing chimeric receptors for CD138 and CD38 antigens and their use
|
|
GB201721802D0
(en)
*
|
2017-12-22 |
2018-02-07 |
Almac Discovery Ltd |
Ror1-specific antigen binding molecules
|
|
CN119019572A
(zh)
|
2017-12-29 |
2024-11-26 |
纪念斯隆-凯特琳癌症中心 |
增强的嵌合抗原受体及其用途
|
|
CA3086832A1
(en)
|
2018-01-03 |
2019-07-11 |
Qu Biologics Inc. |
Innate targeting of adoptive cellular therapies
|
|
SG11202007156QA
(en)
|
2018-02-09 |
2020-08-28 |
Nat Univ Singapore |
Activating chimeric receptors and uses thereof in natural killer cell immunotherapy
|
|
CN109321530B
(zh)
*
|
2018-02-12 |
2021-03-12 |
华东师范大学 |
一种安全型嵌合抗原受体t细胞及其用途
|
|
JP7273421B2
(ja)
|
2018-02-21 |
2023-05-15 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
|
|
SG11202008976YA
(en)
|
2018-04-02 |
2020-10-29 |
Nat Univ Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
WO2019199793A1
(en)
*
|
2018-04-09 |
2019-10-17 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating graft-versus-host disease
|
|
CN110526984A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
一种靶向psma的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN110526976A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
一种靶向psma的单链抗体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN119529091A
(zh)
*
|
2018-06-19 |
2025-02-28 |
南京传奇生物科技有限公司 |
工程化的细胞及其用途
|
|
WO2019244107A1
(en)
*
|
2018-06-21 |
2019-12-26 |
Daiichi Sankyo Company, Limited |
Compositions including cd3 antigen binding fragments and uses thereof
|
|
US12486514B2
(en)
|
2018-08-29 |
2025-12-02 |
National University Of Singapore |
Method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
WO2020065406A2
(en)
|
2018-09-28 |
2020-04-02 |
Immpact-Bio Ltd. |
Methods for identifying activating antigen receptor (acar)/inhibitory chimeric antigen receptor (icar) pairs for use in cancer therapies
|
|
WO2020069508A1
(en)
*
|
2018-09-28 |
2020-04-02 |
Memorial Sloan-Kettering Cancer Center |
Immunoresponsive cells expressing dominant negative fas and uses thereof
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
US12257286B2
(en)
|
2018-10-31 |
2025-03-25 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
WO2020092839A1
(en)
|
2018-10-31 |
2020-05-07 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating cancer
|
|
EP3876956A4
(en)
|
2018-11-08 |
2022-12-28 |
The Regents of The University of California |
SYSTEMS AND METHODS FOR TARGETING CANCER CELLS
|
|
CN109517799B
(zh)
*
|
2018-11-30 |
2022-07-26 |
北京美康基免生物科技有限公司 |
一种基于cd19和cd22的双重嵌合抗原受体基因修饰的免疫细胞及其应用
|
|
WO2020152197A1
(en)
|
2019-01-23 |
2020-07-30 |
Miltenyi Biotec B.V. & Co. KG |
A combination of compositions for elimination and enhanced engraftment of hematopoietic stem cells in the bone marrow of a subject
|
|
CA3130489A1
(en)
*
|
2019-02-18 |
2020-08-27 |
Memorial Sloan-Kettering Cancer Center |
Combinations of multiple chimeric antigen receptors for immunotherapy
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
CA3133333A1
(en)
|
2019-04-30 |
2020-04-30 |
Brian Scott GARRISON |
Chimeric receptors and methods of use thereof
|
|
CN110592014A
(zh)
*
|
2019-08-14 |
2019-12-20 |
广东美赛尔细胞生物科技有限公司 |
一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
|
|
WO2021035093A1
(en)
*
|
2019-08-20 |
2021-02-25 |
Senti Biosciences, Inc. |
Chimeric inhibitory receptor
|
|
EP4022067A4
(en)
*
|
2019-08-28 |
2023-12-20 |
Senti Biosciences, Inc. |
COMBINATORIAL CANCER IMMUNOTHERAPY
|
|
WO2021044213A2
(en)
*
|
2019-09-05 |
2021-03-11 |
Migal-galilee Research Institute Ltd. |
Blocking chimeric antigen receptors for prevention of undesired activation of effector and regulatory immune cells
|
|
WO2021076939A1
(en)
*
|
2019-10-18 |
2021-04-22 |
Board Of Regents, The University Of Texas System |
Hla-restricted vcx/y peptides and t cell receptors and use thereof
|
|
AU2020401315B2
(en)
|
2019-12-11 |
2023-11-09 |
A2 Biotherapeutics, Inc. |
LILRB1-based chimeric antigen receptor
|
|
CN115066249A
(zh)
|
2020-02-04 |
2022-09-16 |
美天施生物科技有限两合公司 |
表达用于感测可溶性抗原的适体嵌合抗原受体的免疫细胞
|
|
TW202144396A
(zh)
*
|
2020-02-20 |
2021-12-01 |
美商聖堤生物科技股份有限公司 |
抑制性嵌合受體架構
|
|
CN111249314B
(zh)
*
|
2020-03-03 |
2022-03-29 |
深圳未知君生物科技有限公司 |
人体共生菌群在提高肿瘤免疫治疗应答中的作用
|
|
WO2021234006A1
(en)
*
|
2020-05-20 |
2021-11-25 |
Miltenyi Biotec B.V. & Co. KG |
Compositions and methods for treating cancer expressing cd90 and cd326
|
|
EP3915578A1
(en)
|
2020-05-28 |
2021-12-01 |
Miltenyi Biotec B.V. & Co. KG |
Chimeric antigen receptor with a spacer comprising c2-set ig-like domains
|
|
WO2022007784A1
(en)
*
|
2020-07-06 |
2022-01-13 |
Nanjing Legend Biotech Co., Ltd. |
Methods of reducing graft rejection of allogeneic cell therapy
|
|
CN116323656A
(zh)
|
2020-07-16 |
2023-06-23 |
优莫佳生物制药股份有限公司 |
门控衔接子靶向受体
|
|
WO2022036065A2
(en)
*
|
2020-08-13 |
2022-02-17 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating cancers
|
|
EP4190808A4
(en)
*
|
2020-08-19 |
2024-07-31 |
Suzhou Immunofoco Biotechnology Co., Ltd. |
Humanized antibody, chimeric antigen receptor, nucleic acid, vector, cell and use
|
|
WO2022040444A1
(en)
|
2020-08-20 |
2022-02-24 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating egfr positive cancers
|
|
EP4100028A4
(en)
|
2020-08-20 |
2023-07-26 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating mesothelin positive cancers
|
|
EP4097486A4
(en)
|
2020-08-20 |
2023-09-06 |
A2 Biotherapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF POSITIVE CANCERS AT CEACAM
|
|
US20220090016A1
(en)
|
2020-09-21 |
2022-03-24 |
A2 Biotherapeutics, Inc. |
Engineered immune cells with micro-clusters
|
|
WO2022096664A1
(en)
|
2020-11-09 |
2022-05-12 |
Miltenyi Biotec B.V. & Co. KG |
Methods and compositions for eliminating engineered immune cells
|
|
CN114569708B
(zh)
*
|
2020-12-02 |
2023-07-04 |
四川大学华西医院 |
Nkg2d car-免疫细胞在抗衰老中应用
|
|
JP2023553861A
(ja)
|
2020-12-02 |
2023-12-26 |
上海復宏漢霖生物技術股▲フン▼有限公司 |
抗ＧＡＲＰ／ＴＧＦβ抗体及び使用方法
|
|
TW202237827A
(zh)
|
2020-12-03 |
2022-10-01 |
美商世紀治療股份有限公司 |
經基因工程改造之細胞及其用途
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
WO2022125578A2
(en)
*
|
2020-12-07 |
2022-06-16 |
The Johns Hopkins University |
Methods of nk cell engineering to enhance tumor targeting
|
|
CN116635064A
(zh)
|
2020-12-18 |
2023-08-22 |
世纪治疗股份有限公司 |
具有适应性受体特异性的嵌合抗原受体系统
|
|
CN114853900A
(zh)
*
|
2021-02-03 |
2022-08-05 |
南京北恒生物科技有限公司 |
新型嵌合抗原受体及其用途
|
|
AU2022221606A1
(en)
|
2021-02-16 |
2023-08-24 |
A2 Biotherapeutics, Inc. |
Compositions and methods for treating her2 positive cancers
|
|
WO2022204129A1
(en)
*
|
2021-03-22 |
2022-09-29 |
Memorial Sloan-Kettering Cancer Center |
Cd38 chimeric co-stimulating receptor and uses thereof
|
|
EP4413031A1
(en)
|
2021-10-06 |
2024-08-14 |
Miltenyi Biotec B.V. & Co. KG |
Method for targeted gene insertion into immune cells
|
|
CA3240585A1
(en)
|
2021-12-17 |
2023-06-22 |
Wenfeng Xu |
Anti-ox40 antibodies, multispecific antibodies and methods of use
|
|
EP4448579A4
(en)
|
2021-12-17 |
2026-02-18 |
Shanghai Henlius Biotech Inc |
ANTI-OX40 ANTIBODIES AND METHODS OF USE
|
|
EP4499708A1
(en)
|
2022-03-25 |
2025-02-05 |
Shanghai Henlius Biotech, Inc. |
Anti-msln antibodies and methods of use
|
|
EP4602171A1
(en)
|
2022-10-15 |
2025-08-20 |
Miltenyi Biotec B.V. & Co. KG |
Transduction of gammadelta t cells with pseudotyped retroviral vectors
|
|
CN116785458A
(zh)
*
|
2023-02-14 |
2023-09-22 |
青岛大学 |
半滑舌鳎抗病蛋白shp-1基因的应用
|
|
CN116376844B
(zh)
*
|
2023-05-31 |
2023-08-11 |
四川大学华西医院 |
包含shp2 sh2结构域的靶向her2阳性肿瘤的car-t及制备方法和应用
|
|
CN119119191B
(zh)
*
|
2024-09-13 |
2025-04-01 |
渤海大学 |
一种海参肠多肽及其在制备胃部疾病药物中的应用
|